Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Charles Balch, M.D. Charles M. Balch, M.D. will serve as a director of the Company upon the effective date of the registration statement of which this prospectus forms a part. Dr. Balch has served as a senior clinical, academic, and executive leader in oncology for more than five decades. He is internationally recognized as a leading authority in melanoma, breast cancer, and cancer immunotherapy, with more than 850 peer-reviewed publications cited over 36,000 times (h-index 90). Since 2015, Dr. Balch has served as Professor and Past Chair of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, where he focuses on mentoring and faculty development. Dr. Bal
This record is keyed to SEC CIK 0002112521 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 8 institutional-holder rows on these vehicles, under 7 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.